Publication Date
An important tool created to guide the development of vaccines against multiple potentially deadly Coronaviruses is being expanded.
The Center for Infectious Disease Research and Policy (CIDRAP) at the University of Minnesota will receive US $3.2 million from the Coalition for Epidemic Preparedness Innovations (CEPI) to advance its open-access Coronavirus Vaccines Research and Development (R&D) Roadmap. CIDRAP will monitor and evaluate R&D progress and catalyse efforts to develop broadly protective vaccines that are effective and long-lasting against currently circulating coronaviruses, as well as new coronaviruses and variants that may emerge in the future.